Melanoma cells which require cyclic AMP for growth View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1975-12

AUTHORS

JOHN PAWELEK, RUTH HALABAN, GAIL CHRISTIE

ABSTRACT

THE cyclic forms of AMP, GMP and CMP have been implicated as agents which either stimulate or inhibit cell division. Pastan et al. reviewed this topic1 and others have dealt with it2–6. Our studies of the growth of cultured melanoma cells have focused on the inhibitory effects of cyclic AMP7. We analysed variant cells that can grow in the presence of agents, such as melanocyte stimulating hormone (MSH), which increase the intracellular levels of cyclic AMP and inhibit the growth of wild-type cells. We describe here a class of variants which are not only resistant to the inhibition, but require cyclic AMP to grow at the rate normally observed in wild-type cells. In one such variant, division was markedly stimulated when either MSH, theophylline, isobutyl methyl xanthine, cholera toxin, prostaglandin E1 (PGE1) or dibutyryl cyclic AMP was added to the medium. Each agent inhibited the growth of wild-type cells. The cells were temperature-sensitive in that they expressed the variant phenotype at 37 °C, but behaved as the wild type at 40 °C. Studies of dose responses to dibutyryl cyclic AMP revealed that growth was also enhanced in the wild type by lower concentrations of the nucleotide (10−5 M), a fact that had gone unnoticed in melanoma cells but has been reported for other cell types1. These findings suggest a stimulatory as well as inhibitory role for cyclic AMP in control of growth of melanoma cells. More... »

PAGES

539-540

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/258539a0

DOI

http://dx.doi.org/10.1038/258539a0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037564605

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/172800


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bucladesine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Division", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, Yale University School of Medicine, 06510, New Haven, Connecticut", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Dermatology, Yale University School of Medicine, 06510, New Haven, Connecticut"
          ], 
          "type": "Organization"
        }, 
        "familyName": "PAWELEK", 
        "givenName": "JOHN", 
        "id": "sg:person.01357521676.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357521676.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, Yale University School of Medicine, 06510, New Haven, Connecticut", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Dermatology, Yale University School of Medicine, 06510, New Haven, Connecticut"
          ], 
          "type": "Organization"
        }, 
        "familyName": "HALABAN", 
        "givenName": "RUTH", 
        "id": "sg:person.053601122.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.053601122.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, 06510, New Haven, Connecticut", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, 06510, New Haven, Connecticut"
          ], 
          "type": "Organization"
        }, 
        "familyName": "CHRISTIE", 
        "givenName": "GAIL", 
        "id": "sg:person.054724221.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.054724221.59"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf02615905", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048877662", 
          "https://doi.org/10.1007/bf02615905"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1975-12", 
    "datePublishedReg": "1975-12-01", 
    "description": "THE cyclic forms of AMP, GMP and CMP have been implicated as agents which either stimulate or inhibit cell division. Pastan et al. reviewed this topic1 and others have dealt with it2\u20136. Our studies of the growth of cultured melanoma cells have focused on the inhibitory effects of cyclic AMP7. We analysed variant cells that can grow in the presence of agents, such as melanocyte stimulating hormone (MSH), which increase the intracellular levels of cyclic AMP and inhibit the growth of wild-type cells. We describe here a class of variants which are not only resistant to the inhibition, but require cyclic AMP to grow at the rate normally observed in wild-type cells. In one such variant, division was markedly stimulated when either MSH, theophylline, isobutyl methyl xanthine, cholera toxin, prostaglandin E1 (PGE1) or dibutyryl cyclic AMP was added to the medium. Each agent inhibited the growth of wild-type cells. The cells were temperature-sensitive in that they expressed the variant phenotype at 37 \u00b0C, but behaved as the wild type at 40 \u00b0C. Studies of dose responses to dibutyryl cyclic AMP revealed that growth was also enhanced in the wild type by lower concentrations of the nucleotide (10\u22125 M), a fact that had gone unnoticed in melanoma cells but has been reported for other cell types1. These findings suggest a stimulatory as well as inhibitory role for cyclic AMP in control of growth of melanoma cells.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/258539a0", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0028-0836", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5535", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "258"
      }
    ], 
    "keywords": [
      "melanoma cells", 
      "prostaglandin E1", 
      "cyclic AMP", 
      "cultured melanoma cells", 
      "dibutyryl cyclic AMP", 
      "isobutyl methyl xanthine", 
      "cholera toxin", 
      "inhibitory role", 
      "inhibitory effect", 
      "methyl xanthine", 
      "variant cells", 
      "dose response", 
      "AMP", 
      "intracellular levels", 
      "presence of agents", 
      "cells", 
      "variant phenotypes", 
      "wild-type cells", 
      "cell types1", 
      "agents", 
      "such variants", 
      "wild type", 
      "control of growth", 
      "hormone", 
      "class of variants", 
      "low concentrations", 
      "stimulatory", 
      "inhibition", 
      "study", 
      "variants", 
      "MSH", 
      "toxin", 
      "phenotype", 
      "xanthine", 
      "GMP", 
      "E1", 
      "findings", 
      "response", 
      "levels", 
      "control", 
      "growth", 
      "role", 
      "types", 
      "rate", 
      "effect", 
      "presence", 
      "cell division", 
      "concentration", 
      "nucleotides", 
      "types1", 
      "division", 
      "form", 
      "medium", 
      "fact", 
      "class", 
      "CMP", 
      "topic1", 
      "cyclic form"
    ], 
    "name": "Melanoma cells which require cyclic AMP for growth", 
    "pagination": "539-540", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037564605"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/258539a0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "172800"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/258539a0", 
      "https://app.dimensions.ai/details/publication/pub.1037564605"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_114.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/258539a0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/258539a0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/258539a0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/258539a0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/258539a0'


 

This table displays all metadata directly associated to this object as RDF triples.

163 TRIPLES      21 PREDICATES      91 URIs      82 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/258539a0 schema:about N51c1d18d04c446d7a5c83a168eb4ca79
2 Nbf00f506245f47e6becb0301bda92be5
3 Nc4335f9976b4468db8568b0411873cdf
4 Nd9307031d4d44d7fb11c4a74075e91c7
5 Nf28ceb6cfce44f418bad7c4914598dec
6 Nfb14b1a373a745de82140e4e1a876a53
7 anzsrc-for:11
8 anzsrc-for:1112
9 schema:author Nfebd2b0b75654ea09f477f89b0dc9b12
10 schema:citation sg:pub.10.1007/bf02615905
11 schema:datePublished 1975-12
12 schema:datePublishedReg 1975-12-01
13 schema:description THE cyclic forms of AMP, GMP and CMP have been implicated as agents which either stimulate or inhibit cell division. Pastan et al. reviewed this topic1 and others have dealt with it2–6. Our studies of the growth of cultured melanoma cells have focused on the inhibitory effects of cyclic AMP7. We analysed variant cells that can grow in the presence of agents, such as melanocyte stimulating hormone (MSH), which increase the intracellular levels of cyclic AMP and inhibit the growth of wild-type cells. We describe here a class of variants which are not only resistant to the inhibition, but require cyclic AMP to grow at the rate normally observed in wild-type cells. In one such variant, division was markedly stimulated when either MSH, theophylline, isobutyl methyl xanthine, cholera toxin, prostaglandin E1 (PGE1) or dibutyryl cyclic AMP was added to the medium. Each agent inhibited the growth of wild-type cells. The cells were temperature-sensitive in that they expressed the variant phenotype at 37 °C, but behaved as the wild type at 40 °C. Studies of dose responses to dibutyryl cyclic AMP revealed that growth was also enhanced in the wild type by lower concentrations of the nucleotide (10−5 M), a fact that had gone unnoticed in melanoma cells but has been reported for other cell types1. These findings suggest a stimulatory as well as inhibitory role for cyclic AMP in control of growth of melanoma cells.
14 schema:genre article
15 schema:isAccessibleForFree false
16 schema:isPartOf N066d7905424344889c96133d6521e01d
17 Ndc3e896acd4a48c6970fda412be4de64
18 sg:journal.1018957
19 schema:keywords AMP
20 CMP
21 E1
22 GMP
23 MSH
24 agents
25 cell division
26 cell types1
27 cells
28 cholera toxin
29 class
30 class of variants
31 concentration
32 control
33 control of growth
34 cultured melanoma cells
35 cyclic AMP
36 cyclic form
37 dibutyryl cyclic AMP
38 division
39 dose response
40 effect
41 fact
42 findings
43 form
44 growth
45 hormone
46 inhibition
47 inhibitory effect
48 inhibitory role
49 intracellular levels
50 isobutyl methyl xanthine
51 levels
52 low concentrations
53 medium
54 melanoma cells
55 methyl xanthine
56 nucleotides
57 phenotype
58 presence
59 presence of agents
60 prostaglandin E1
61 rate
62 response
63 role
64 stimulatory
65 study
66 such variants
67 topic1
68 toxin
69 types
70 types1
71 variant cells
72 variant phenotypes
73 variants
74 wild type
75 wild-type cells
76 xanthine
77 schema:name Melanoma cells which require cyclic AMP for growth
78 schema:pagination 539-540
79 schema:productId N67ec7388be6a4f88b093d21aa6c2ac47
80 N8037a04a20004912b28b36fc9e0d2283
81 Nac2ee646d3274c54a477d10cb48e9480
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037564605
83 https://doi.org/10.1038/258539a0
84 schema:sdDatePublished 2022-09-02T15:44
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher N2c8bc6eed51c47b68b13e24a9a9a247a
87 schema:url https://doi.org/10.1038/258539a0
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N066d7905424344889c96133d6521e01d schema:issueNumber 5535
92 rdf:type schema:PublicationIssue
93 N2c8bc6eed51c47b68b13e24a9a9a247a schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 N51c1d18d04c446d7a5c83a168eb4ca79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Mutation
97 rdf:type schema:DefinedTerm
98 N67ec7388be6a4f88b093d21aa6c2ac47 schema:name pubmed_id
99 schema:value 172800
100 rdf:type schema:PropertyValue
101 N8037a04a20004912b28b36fc9e0d2283 schema:name dimensions_id
102 schema:value pub.1037564605
103 rdf:type schema:PropertyValue
104 N8d1b26f44a10470e83930e01a6f21b30 rdf:first sg:person.053601122.01
105 rdf:rest Nf2d2d556866e4c2a80f16ed4ad4ea072
106 Nac2ee646d3274c54a477d10cb48e9480 schema:name doi
107 schema:value 10.1038/258539a0
108 rdf:type schema:PropertyValue
109 Nbf00f506245f47e6becb0301bda92be5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Melanoma
111 rdf:type schema:DefinedTerm
112 Nc4335f9976b4468db8568b0411873cdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Bucladesine
114 rdf:type schema:DefinedTerm
115 Nd9307031d4d44d7fb11c4a74075e91c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Dose-Response Relationship, Drug
117 rdf:type schema:DefinedTerm
118 Ndc3e896acd4a48c6970fda412be4de64 schema:volumeNumber 258
119 rdf:type schema:PublicationVolume
120 Nf28ceb6cfce44f418bad7c4914598dec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Cell Line
122 rdf:type schema:DefinedTerm
123 Nf2d2d556866e4c2a80f16ed4ad4ea072 rdf:first sg:person.054724221.59
124 rdf:rest rdf:nil
125 Nfb14b1a373a745de82140e4e1a876a53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Cell Division
127 rdf:type schema:DefinedTerm
128 Nfebd2b0b75654ea09f477f89b0dc9b12 rdf:first sg:person.01357521676.69
129 rdf:rest N8d1b26f44a10470e83930e01a6f21b30
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
134 schema:name Oncology and Carcinogenesis
135 rdf:type schema:DefinedTerm
136 sg:journal.1018957 schema:issn 0028-0836
137 1476-4687
138 schema:name Nature
139 schema:publisher Springer Nature
140 rdf:type schema:Periodical
141 sg:person.01357521676.69 schema:affiliation grid-institutes:grid.47100.32
142 schema:familyName PAWELEK
143 schema:givenName JOHN
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357521676.69
145 rdf:type schema:Person
146 sg:person.053601122.01 schema:affiliation grid-institutes:grid.47100.32
147 schema:familyName HALABAN
148 schema:givenName RUTH
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.053601122.01
150 rdf:type schema:Person
151 sg:person.054724221.59 schema:affiliation grid-institutes:grid.47100.32
152 schema:familyName CHRISTIE
153 schema:givenName GAIL
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.054724221.59
155 rdf:type schema:Person
156 sg:pub.10.1007/bf02615905 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048877662
157 https://doi.org/10.1007/bf02615905
158 rdf:type schema:CreativeWork
159 grid-institutes:grid.47100.32 schema:alternateName Department of Dermatology, Yale University School of Medicine, 06510, New Haven, Connecticut
160 Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, 06510, New Haven, Connecticut
161 schema:name Department of Dermatology, Yale University School of Medicine, 06510, New Haven, Connecticut
162 Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, 06510, New Haven, Connecticut
163 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...